estradiol levels at trigger (p-trend¼0.04) despite no differences in the total dose of gonadotropins. Specifically, women in the highest quartile of temperature (76.0-81.4 F) had an average estradiol level of 3761 pg/mL (95% CI 3403, 4119) compared to 3341 pg/mL (95% CI 3034, 3647) among women in the lowest quartile (38.6-49.6 F). There was no impact of temperature on oocyte counts. Lower temperatures and higher humidity prior to oocyte retrieval were associated with a slightly higher percentage of usable embryos after oocyte warming and fertilization (p-trend¼0.03 and 0.04). Greater mean precipitation prior to oocyte retrieval was associated with a slightly higher percentage of mature oocytes retrieved (p-trend¼0.06) but was not associated with any of the IVF outcomes.. CONCLUSIONS: While warmer temperatures prior to oocyte retrieval were associated with higher estradiol levels at trigger, the resulting oocytes resulted in a lower percentage of useable embryos once thawed and fertilized among recipients. Vitrified oocyte donation banks represent an excellent model to determine the impact of environmental exposure such as climate variables on IVF outcomes given that exposures experienced by the donor and recipient are uncorrelated in time and space.SUPPORT: Supported in part by R00ES026648 from the NIEHS.
To assess the effect of repetitive transvaginal ovarian needle punctures as compared to laparoscopic ovarian drilling on antral follicle counts (AFC), serum antimulerian hormone levels (AMH) and pregnancy rates in anovulatory women with PCOS.DESIGN: A six month cohort study was undertaken to compare outcomes in PCOS women who underwent transvaginal ultrasound guided ovarian injury using a 16 gauge oocyte collection needle and PCOS women with laparoscopic ovarian drilling (dithermy, 8 punctures). Couples with significant sperm abnormalities were excluded.MATERIALS AND METHODS: 126 anovulatory subjects, 67 with ovarian injury (OI) due to a trans-vaginal in-vitro maturation collection (which failed to result in pregnancy) and 59 who underwent laparoscopic ovarian drilling (LOD) were compared. Primary outcome was spontaneous pregnancy rate. In addition body mass index (BMI), AFC and AMH levels were measured pre intervention and at the 3rd and 6th months. Both groups received no further treatments. Shapiro Wilk's test was used for assessing normal distribution. Chi-squared, T tests or Mann Whitney U test were used. Data is presented as meanAESD or median (range).RESULTS: Pretreatment, median serum total testosterone level were higher in the OI than the LOD groups(P¼0.001), other hormone levels were similar. BMI at time 0, 3 and 6 months did not differ between the two interventions. However, serum AMH levels were lower at time 0, 3 months and 6 months (p<0.001) in the LOD when compared to the OI group. At 3 and 6 months AMH levels decreased more significantly in the LOD than the OI group (-26.4% (-41.5 to -5.5) vs. -12.5% (-26.3 to -0.9), p<0.001)) and (-29.2% (-55.6 to -3.5) vs. -12.6% (-28.7 to 1.86), p<0.001)), respectively. % decrease in AFC was also greater in the LOD group than the OI subjects at 3 months (-24% (-37 to -8) vs. -12% (-56 to 0) , p<0.001) and at 6 months (-27% (-44 to-4) vs. -5% (-29 to 9), p<0.001). However cumulative pregnancy rates at 6 months were similar LOD (35%) vs OI (55%) (P>0.05).CONCLUSIONS: Although, ultrasound guided transvaginal ovarian needle injury results in less significant improvements in AMH and AFC levels in anovulatory PCOS women than does LOD, pregnancy rates trended higher with this OI. This suggests a less invasive method of ovarian injury may be available than laparoscopy for patients requiring this mechanism to conceive.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.